TNF Pharmaceuticals, Inc. (TNFA)

TNF Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.19	2.68	0.75	0.56	0.15	0.13
Short-Term Investments	9.45	2.24	4.09	11	-	-
Cash & Short-Term Investments	10.64	4.92	4.84	11.56	0.15	0.13
Cash Growth	25.60%	1.80%	-58.16%	7695.20%	12.32%	-76.44%
Prepaid Expenses	1.39	0.89	0.57	1.11	0	0.02
Total Current Assets	12.03	5.82	5.4	12.67	0.15	0.15
Property, Plant & Equipment	0.02	0.05	0.14	0.15	0.53	-
Long-Term Investments	1.5	1.5	1.5	1.5	-	-
Goodwill	10.5	10.5	10.5	10.5	-	-
Other Intangible Assets	-	-	-	-	-	0.02
Total Assets	24.04	17.86	17.54	24.81	0.68	0.17
Accounts Payable	3.71	3.08	2.36	0.87	1.1	0.88
Accrued Expenses	0.46	0.64	0.32	0.12	0.7	0.01
Short-Term Debt	-	-	-	-	0.07	0.01
Current Portion of Leases	0.02	0.05	0.07	0.05	0.48	-
Other Current Liabilities	2.81	1.22	0.03	-	-	-
Total Current Liabilities	6.99	4.99	2.77	1.04	2.35	0.9
Long-Term Debt	-	-	-	-	3.53	0.99
Long-Term Leases	-	-	0.08	0.1	0.05	-
Other Long-Term Liabilities	-	0.1	-	0.03	-	-
Total Liabilities	6.99	5.09	2.84	1.17	5.93	1.89
Common Stock	0	0	0	102.06	0	0
Additional Paid-In Capital	142.63	114.2	108.31	-	43.41	36.85
Retained Earnings	-126	-101.98	-93.76	-78.56	-48.67	-38.58
Total Common Equity	16.63	12.23	14.55	23.5	-5.26	-1.73
Shareholders' Equity	17.06	12.77	14.7	23.65	-5.26	-1.73
Total Liabilities & Equity	24.04	17.86	17.54	24.81	0.68	0.17
Total Debt	0.02	0.05	0.14	0.15	4.13	1
Net Cash (Debt)	10.62	4.87	4.69	11.41	-3.98	-0.87
Net Cash Growth	26.78%	3.83%	-58.86%	-	-	-
Net Cash Per Share	4.90	3.16	3.63	9.78	-4.24	-0.69
Filing Date Shares Outstanding	2.76	2.16	1.32	1.27	1.34	1.27
Total Common Shares Outstanding	2.47	2.02	1.32	1.26	1.34	1.27
Working Capital	5.04	0.83	2.63	11.63	-2.2	-0.75
Book Value Per Share	6.73	6.06	11.06	18.72	-3.94	-1.36
Tangible Book Value	6.13	1.73	4.05	13	-5.26	-1.74
Tangible Book Value Per Share	2.48	0.86	3.08	10.36	-3.94	-1.38

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q